OptimizeRx (OPRX) Non-Current Assets (2010 - 2026)

OptimizeRx has disclosed Non-Current Assets across 17 years of filings, most recently posting $110.2 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 4.35% year-over-year to $110.2 million; the TTM figure through Jun 2026 stood at $447.5 million (down 4.13% YoY), while the FY2025 annual figure was $112.2 million, down 4.26% from the prior year.
• Non-Current Assets came in at $110.2 million for Q2 2026 at OptimizeRx, down from $111.1 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $129.0 million in Q4 2023 to a low of $25.4 million in Q1 2022.
• Average Non-Current Assets over 5 years is $85.7 million, with a median of $111.7 million recorded in 2025.
• Year-over-year, Non-Current Assets jumped 257.71% in 2023 and decreased 9.34% in 2025.
• Over 5 years, Non-Current Assets stood at $36.1 million in 2022, then jumped by 257.71% to $129.0 million in 2023, then dropped by 9.18% to $117.2 million in 2024, then declined by 4.26% to $112.2 million in 2025, then decreased by 1.81% to $110.2 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $110.2 million in Q2 2026, $111.1 million in Q1 2026, and $112.2 million in Q4 2025.